1. Home
  2. GRABW vs XOMAO Comparison

GRABW vs XOMAO Comparison

Compare GRABW & XOMAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grab Holdings Limited Warrant

GRABW

Grab Holdings Limited Warrant

N/A

Current Price

$0.37

Market Cap

0.0

ML Signal

N/A

Logo AGNC Investment Corp.

XOMAO

AGNC Investment Corp.

BUY

Current Price

$25.52

Market Cap

0.0

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
GRABW
XOMAO
Founded
2012
N/A
Country
Singapore
United States
Employees
11267
13
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GRABW
XOMAO
Price
$0.37
$25.52
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
54.7K
N/A
Earning Date
02-21-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,686,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
21.65
N/A
52 Week Low
$0.15
N/A
52 Week High
$0.59
N/A

Technical Indicators

Market Signals
Indicator
GRABW
XOMAO
Relative Strength Index (RSI) 47.60 54.90
Support Level $0.34 $24.86
Resistance Level $0.37 $25.58
Average True Range (ATR) 0.02 0.17
MACD 0.00 0.01
Stochastic Oscillator 52.05 86.18

Price Performance

Historical Comparison
GRABW
XOMAO

About GRABW Grab Holdings Limited Warrant

Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore, Indonesia, and Malaysia contributed more than 70% of revenue in 2024. Grab's main competitors in Southeast Asia are Line Man and Goto. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.

About XOMAO AGNC Investment Corp.

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: